These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease. Bansal N; Zelnick L; Bhat Z; Dobre M; He J; Lash J; Jaar B; Mehta R; Raj D; Rincon-Choles H; Saunders M; Schrauben S; Weir M; Wright J; Go AS; J Am Coll Cardiol; 2019 Jun; 73(21):2691-2700. PubMed ID: 31146814 [TBL] [Abstract][Full Text] [Related]
10. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial. Anker SD; Butler J; Filippatos G; Khan MS; Marx N; Lam CSP; Schnaidt S; Ofstad AP; Brueckmann M; Jamal W; Bocchi EA; Ponikowski P; Perrone SV; Januzzi JL; Verma S; Böhm M; Ferreira JP; Pocock SJ; Zannad F; Packer M Circulation; 2021 Jan; 143(4):337-349. PubMed ID: 33175585 [TBL] [Abstract][Full Text] [Related]
11. Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial. Filippatos G; Pitt B; Agarwal R; Farmakis D; Ruilope LM; Rossing P; Bauersachs J; Mentz RJ; Kolkhof P; Scott C; Joseph A; Bakris GL; Anker SD; Eur J Heart Fail; 2022 Jun; 24(6):996-1005. PubMed ID: 35239204 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved. Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD; JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067 [TBL] [Abstract][Full Text] [Related]
13. Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Bhm M; Anker S; Mahfoud F; Lauder L; Filippatos G; Ferreira JP; Pocock SJ; Brueckmann M; Saloustros I; Schler E; Wanner C; Zannad F; Packer M; Butler J Eur Heart J; 2023 Feb; 44(5):396-407. PubMed ID: 36478225 [TBL] [Abstract][Full Text] [Related]
14. Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation. Filippatos G; Farmakis D; Butler J; Zannad F; Ferreira JP; Ofstad AP; Iwata T; Brueckmann M; Pocock SJ; Packer M; Anker SD; Eur J Heart Fail; 2023 Jul; 25(7):970-977. PubMed ID: 37062866 [TBL] [Abstract][Full Text] [Related]
15. Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Levin A; Perkovic V; Wheeler DC; Hantel S; George JT; von Eynatten M; Koitka-Weber A; Wanner C; Clin J Am Soc Nephrol; 2020 Oct; 15(10):1433-1444. PubMed ID: 32994159 [TBL] [Abstract][Full Text] [Related]
16. Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs. Ferreira JP; Pitt B; McMurray JJV; Pocock SJ; Solomon SD; Pfeffer MA; Zannad F; Rossignol P JACC Heart Fail; 2022 Nov; 10(11):842-850. PubMed ID: 36328653 [TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial. Butler J; Usman MS; Filippatos G; Ferreira JP; Böhm M; Brueckmann M; Januzzi JL; Kaul S; Piña IL; Ponikowski P; Senni M; Sumin M; Verma S; Zaremba-Pechmann L; Pocock SJ; Packer M; Anker S JAMA Cardiol; 2023 Jul; 8(7):640-649. PubMed ID: 37223933 [TBL] [Abstract][Full Text] [Related]
18. The kidney and cardiovascular outcome trials. Bloomgarden Z J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006 [TBL] [Abstract][Full Text] [Related]
19. Empagliflozin in Patients with Chronic Kidney Disease. ; Herrington WG; Staplin N; Wanner C; Green JB; Hauske SJ; Emberson JR; Preiss D; Judge P; Mayne KJ; Ng SYA; Sammons E; Zhu D; Hill M; Stevens W; Wallendszus K; Brenner S; Cheung AK; Liu ZH; Li J; Hooi LS; Liu W; Kadowaki T; Nangaku M; Levin A; Cherney D; Maggioni AP; Pontremoli R; Deo R; Goto S; Rossello X; Tuttle KR; Steubl D; Petrini M; Massey D; Eilbracht J; Brueckmann M; Landray MJ; Baigent C; Haynes R N Engl J Med; 2023 Jan; 388(2):117-127. PubMed ID: 36331190 [TBL] [Abstract][Full Text] [Related]
20. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank. Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW; Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]